Portugal's mental health crisis fuels record psychotropic drug use in 2025
Portugal's mental health crisis fuels record psychotropic drug use in 2025
Portugal's mental health crisis fuels record psychotropic drug use in 2025
This view is shared by Miguel Ricou, president of the Clinical and Health Psychology Specialty Council of the Portuguese Psychologists Association, who states that after the COVID-19 pandemic, people are seeking help more readily—but many end up "hitting a wall" due to the difficulty of accessing mental health care.
The psychologist explained that accessibility is particularly critical in this field, as people often seek help at specific moments of need. "They look for support, can't get access, and then a long time may pass before they try again."
By the time they finally secure an appointment, he added, "they may no longer be in the same mindset or available to begin treatment."
"It's a shame. We need to improve access to mental health professionals," Ricou emphasized.
The experts spoke to Lusa regarding the surge in psychotropic drug sales, which reached nearly 29.4 million packages in 2025—the highest figure in the past decade—with costs to Portugal's National Health Service (SNS) approaching €152 million, according to data from the National Authority of Medicines and Health Products (Infarmed).
Albino Oliveira-Maia, director of the Neuropsychiatry Unit at the Champalimaud Foundation, noted "a clear trend toward greater and better accessibility, both in primary care and, in the case of mental health, in specialized services", though progress remains insufficient.
He acknowledged that some prescriptions could be avoided if there were "sufficient and timely access to alternative care, such as psychotherapy."
Miguel Ricou added that the lack of alternatives helps explain the rise in drug consumption. "If people can't access these professionals, of course family doctors have no choice but to prescribe medication," he said, advocating for stronger mental health teams.
He also stressed the need for professionals to work together and communicate effectively. Otherwise, he warned, "we end up with scattered interventions, lacking consistency and continuity."
Ana Matos Pires, a psychiatrist with the National Coordination for Mental Health Policies, suggested the data may indicate that "people are more aware—particularly of severe mental illness, such as major depression and psychotic disorders—and are seeking help."
Matos Pires added that mental health reforms and the expansion of community teams have enabled earlier intervention, improving access. However, she emphasized that these conditions "cannot be treated with psychotropic drugs alone" and also require psychotherapeutic and psychoeducational approaches.
Oliveira-Maia further noted that psychiatric disorders are a leading cause of health-related loss of function, arguing that investment in this area should match the burden of disease—a goal he says has not yet been met.
"There is, however, greater attention to the problem and growing public demand for solutions. The expectation is that progress will continue, with mental health care becoming increasingly comprehensive and higher in quality, both within the National Health Service and beyond," he concluded.